Search results - 13 results
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study.
Pebody, Richard; WHO European Respiratory Surveillance Network Source: Lancet Respir Med, Volume 12, Issue 9 (2024) Keywords: Adult Aged Aged, 80 and over COVID-19 COVID-19 Vaccines Europe Female Humans ...
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study.
Pebody, Richard; WHO European Respiratory Surveillance Network Source: Lancet Respir Med, Volume 12, Issue 9 (2024) Keywords: Adult Aged Aged, 80 and over COVID-19 COVID-19 Vaccines Europe Female Humans ...
Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae.
Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group Source: Lancet Microbe, Volume 5, Issue 6 (2024) Keywords: Disease Outbreaks Humans Mycoplasma ...
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
SARI Surveillance Network (BelsariNet) Source: Influenza Other Respir Viruses, Volume 18, Issue 2 (2024) Keywords: Adult Case-Control Studies Europe Hospitalization hospitals Humans Influenza A Virus, ...
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Keywords: COVID-19 Humans Pandemics Population Surveillance Respiratory Syncytial Virus Infections Respiratory Syncytial Virus, Human SARS-CoV-2 Seasons Abstract: BACKGROUND: The emergence of the Severe Acute ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Vaccines Europe Hospitalization Humans Pneumonia RNA, Messenger SARS-CoV-2 Vaccine Efficacy Abstract: IntroductionThe I- MOVE- COVID-19 and VEBIS hospital networks have been measuring COVID-19 vaccine ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
study teams (in addition to the named authors) Source: Euro Surveill, Volume 28, Issue 47 (2023) Keywords: Adult BNT162 Vaccine COVID-19 Europe Hospitalization Humans RNA, Viral SARS-CoV-2 Vaccine ...
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
Joana Gomes Dias; Sonja J Olsen Source: Euro Surveill, Volume 28, Issue 4 (2023) Keywords: Aged Antiviral Agents Enzyme Inhibitors Guanidines Hospital Mortality Humans Influenza, Human Neuraminidase ...
Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?
Source: Lancet Microbe, Volume 3, Issue 12 (2022) Keywords: Antibodies, Bacterial COVID-19 Humans Mycoplasma pneumoniae Pandemics Pneumonia, Mycoplasma Health Topics: Acute respiratory tract infection ...
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.
3 (2021) Abstract: Background: Seasonal human coronaviruses (hCoVs) broadly circulate in humans. Their epidemiology and effect on the spread of emerging coronaviruses has been neglected thus far. We aimed to ...